28 BIOGAIA SUSTAINABILITY REPORT 2021 Responsible suppliers Objective 2021 Did we do it Outcome 2021 Assess need for further development of how sustainability risks in the supply chain are managed. Not started Due to a lack of resources, BioGaia did not initiate an assessment in 2021 of the need for further development of how sustainability risks in the supply chain are managed. Continue to study the opportunities for improvement by suppliers identified in the life-cycle assessment. Ongoing Discussions are ongoing but have yet to result in concrete measures. An updated life-cycle assessment of bottle and blister packaging was conducted using additional data from suppliers. Objective 2022 To include the sustainability assessment of suppliers in the Supplier Risk Assessment process. Long-term objectives Assess need for further development of how sustainability risks in the supply chain are managed. Responsible partners Objective 2021 Did we do it Outcome 2021 Evaluate and improve new process to assess distributors. Ongoing All new distributors in markets with an assessed higher risk were evaluated using an external tool. No higher risk was identified for these distributors. 100% of partners must have signed BioGaia’s Code of Conduct. Ongoing 97% of BioGaia’s partners had signed the Code of Conduct in 2021 and active efforts are ongoing to cover the remaining partners in 2022. Objective 2022 100% of all new distributors are to sign the Code of Conduct. Long-term objectives Further develop the process for evaluating new distributors. Responsible research Objective 2021 Did we do it Outcome 2021 Further development of work to promote independent studies with BioGaia’s strains. Yes 22 independent studies published in 2021 and the process for managing inquiries about new research was updated. Continue to evaluate the need for additional policies and processes. Yes In 2021, BioGaia updated the company’s guidelines for sponsorship of clinical studies. Objective 2022 Sequencing, genomics and safety studies will begin as part of the development of new strains. Summary – Healthy networks Healthy networks CONTENTS
RkJQdWJsaXNoZXIy NjAyMDA=